FI894225A - Etoposidloesningar. - Google Patents

Etoposidloesningar. Download PDF

Info

Publication number
FI894225A
FI894225A FI894225A FI894225A FI894225A FI 894225 A FI894225 A FI 894225A FI 894225 A FI894225 A FI 894225A FI 894225 A FI894225 A FI 894225A FI 894225 A FI894225 A FI 894225A
Authority
FI
Finland
Prior art keywords
solution
etoposidloesningar
dimethylisosorbide
etoposide
formulated
Prior art date
Application number
FI894225A
Other languages
English (en)
Other versions
FI894225A0 (fi
Inventor
Richard G Corrao
Murray A Kaplan
Edward J Bara
Ismat Ullah
Shreeram Narahari Agharkar
Gururaj Bykadi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI894225A0 publication Critical patent/FI894225A0/fi
Publication of FI894225A publication Critical patent/FI894225A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI894225A 1988-09-12 1989-09-07 Etoposidloesningar. FI894225A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/243,392 US4927638A (en) 1986-10-08 1988-09-12 Etoposide solutions

Publications (2)

Publication Number Publication Date
FI894225A0 FI894225A0 (fi) 1989-09-07
FI894225A true FI894225A (fi) 1990-03-13

Family

ID=22918600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894225A FI894225A (fi) 1988-09-12 1989-09-07 Etoposidloesningar.

Country Status (14)

Country Link
US (1) US4927638A (fi)
EP (1) EP0359184B1 (fi)
JP (1) JPH02115126A (fi)
KR (1) KR900004322A (fi)
AT (1) ATE83150T1 (fi)
AU (1) AU616049B2 (fi)
DE (1) DE68903814T2 (fi)
DK (1) DK446889A (fi)
FI (1) FI894225A (fi)
GR (1) GR3006501T3 (fi)
IE (1) IE892898L (fi)
IL (1) IL91598A0 (fi)
PT (1) PT91682B (fi)
ZA (1) ZA896916B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (ko) * 1990-01-19 1991-08-31 디께다 가즈히꼬 에토포시드-2-디메틸아미노 화합물의 동결건조 제제
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
DK1033128T4 (da) 1993-09-28 2012-03-19 Scherer Gmbh R P Blød gelatinekapselfremstilling
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
DE69531611T2 (de) * 1994-04-28 2004-02-26 Bionumerik Pharmaceuticals, Inc., San Antonio Lactone-stabile camptothecin oder 7 - ethyl camptothecin - formulierung in dimethylisosorbid oder dimethylacetamid
EP0839029A1 (en) * 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
AU4609200A (en) * 1999-01-28 2000-08-18 Shashikant Prabhudas Kurani Novel injectable antimalarial compositions of artemisinin
EP1289560A1 (en) * 2000-06-12 2003-03-12 SmithKline Beecham Corporation Novel solid dispersion compositions
WO2006034147A2 (en) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions and methods for the preparation and administration of poorly water soluble drugs
MX2008013576A (es) * 2006-04-24 2009-01-07 Bruce Medical Ab Agentes anticancerigenos a base de polimeros.
US9011843B2 (en) * 2006-12-14 2015-04-21 Master Supplements, Inc. Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
CA2938974C (en) 2014-02-07 2023-08-22 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
JPS60239415A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド注射剤
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS60239414A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド溶液の変色抑制方法
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤

Also Published As

Publication number Publication date
PT91682B (pt) 1995-05-31
GR3006501T3 (fi) 1993-06-30
IL91598A0 (en) 1990-04-29
ATE83150T1 (de) 1992-12-15
DE68903814D1 (de) 1993-01-21
DE68903814T2 (de) 1993-04-08
KR900004322A (ko) 1990-04-12
IE892898L (en) 1990-03-12
AU4130189A (en) 1990-03-15
EP0359184A1 (en) 1990-03-21
EP0359184B1 (en) 1992-12-09
US4927638A (en) 1990-05-22
ZA896916B (en) 1991-08-28
FI894225A0 (fi) 1989-09-07
DK446889D0 (da) 1989-09-11
PT91682A (pt) 1990-03-30
DK446889A (da) 1990-03-13
JPH02115126A (ja) 1990-04-27
AU616049B2 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
FI894225A0 (fi) Etoposidloesningar.
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
NL940006I1 (nl) 1,2-Benzisoxyzol-3-yl- en 1,2-benzisothiazol-3-yl-derivaten
DE10075034I1 (de) Insulinderivate
NO178834C (no) Innretning for avviksboring
DK673489D0 (da) Overtrukne klaebetabletter
FR2631232B1 (fr) Adsorbats medicamenteux
DK245087A (da) Triazolderivater samt herbicid indeholdende et saadant
PT91631A (pt) A process for the preparation of cyclic graf-analogs ii
KR900702583A (ko) 초전도성 복합체
DK370589A (da) Todelt emballage med plan top
DK470886D0 (da) Oxazol- og isoxazolderivater
DE68926629D1 (de) Supraleitender Transistor
DK158598C (da) Penicillinpraeparat til rektal administration
KR900002299U (ko) 해태제조기의 해태분사장치
KR890006371U (ko) 포장침
DK620987D0 (da) Renin-inhibitorer med et lactam-pseudodipeptid
NO883120D0 (no) Fremgangsmaate for aa redusere gjennomtrengeligheten av sterkt gjennomtrengelige soner i en undergrunnsformasjon.
DK164221C (da) Gassifikationsproces
IT8859013V0 (it) Progetto di sviluppo del metodo antifecondativo ogino knaus della contenzione periodica usando 1 termometro elettronico.
RO82025A2 (ro) Medicament vasodilatator si antihistaminic
SE8601839D0 (sv) Kapsel med mjukt lock
IT8848384A0 (it) Capsula per farmaco con parti compenetrabili
BR6601860U (pt) Capsula com ornamento
BR8800601A (pt) Ronda imobiliaria

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BRISTOL-MYERS SQUIBB COMPANY